<DOC>
	<DOCNO>NCT01609920</DOCNO>
	<brief_summary>The aim study examine diagnostic performance gadofosveset enhance magnetic resonance imaging lymphography ( MRL ) . The diagnostic performance MRL determine basis node-to-node match imaged node definitive histopathology . The pathologic examination sentinel lymph node biopsy ( SLNB ) axillary lymph node dissection ( ALND ) regard golden standard nodal involvement .</brief_summary>
	<brief_title>Nodal Staging Breast Cancer With MRL</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Female patient histopathologically confirm breast cancer undergo nodal stag . 2 . Willing able undergo study procedures 3 . Has personally provide write informed consent . 1 . Age &lt; 18 , 2 . Pregnancy 3 . Contra indication MRL pacemaker , aneurysm clip severe claustrophobia . 4 . Allergy ingredient Gadofosveset ( Vasovist® /Ablavar® ) 5 . Being unable give inform consent person 6 . Acute chronic severe renal insufficiency ( glomerular filtration rate &lt; 45 mL/min/1.73m2 ) 1 . 7 . Acute renal insufficiency severity due hepatorenal syndrome . 8 . Known ( suspicion ) QT prolongation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>MRI</keyword>
	<keyword>lymph node metastasis</keyword>
	<keyword>breast cancer</keyword>
	<keyword>gadofosveset</keyword>
</DOC>